Brief: Timber Pharmaceuticals Expect To Complete Enrollment Of Patients In Both TMB-001 And TMB-002 Studies During Early Months Of 2021

Trex Wind-Down

18/08/2020 21:40

Aug 18 (Reuters) - Timber Pharmaceuticals Inc  TMBR.A :
    * TIMBER PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
ANNOUNCES
SECOND QUARTER 2020 FINANCIAL RESULTS
    * TIMBER PHARMACEUTICALS - EXPECT TO COMPLETE ENROLLMENT OF
PATIENTS IN BOTH TMB-001 AND TMB-002 STUDIES DURING EARLY MONTHS
OF 2021
    * TIMBER PHARMACEUTICALS - EXPECT CASH BALANCE OF NEARLY $14
MILLION WILL FUND TRIALS & OPERATIONS THROUGH COMPLETION OF
CURRENT TMB-001 & TMB-002 STUDIES

Source text for Eikon:  ID:nGNX30fqs3 
Further company coverage:  TMBR.A 

 ((Reuters.Briefs@thomsonreuters.com;))